Nan Shan Life Insurance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.6M | Sell |
|
|||||
|
2025
Q1 | $57.5M | Hold |
|
|||||
|
2024
Q4 | $53.4M | Sell |
|
|||||
|
2024
Q3 | $66.3M | Sell |
|
|||||
|
2024
Q2 | $54.1M | Sell |
|
|||||
|
2024
Q1 | $72.2M | Hold |
|
|||||
|
2023
Q4 | $68.3M | Hold |
|
|||||
|
2023
Q3 | $77.2M | Buy |
|
|||||
|
2023
Q2 | $77.3M | Buy |
|
|||||
|
2023
Q1 | $63.6M | Buy |
|
|||||
|
2022
Q4 | $42.8M | Sell |
|
|||||
|
2022
Q3 | $83.2M | Buy |
|
|||||
|
2022
Q2 | $43.2M | Sell |
|
|||||
|
2022
Q1 | $114M | Hold |
|
|||||
|
2021
Q4 | $97.2M | Buy |
|
|||||
|
2021
Q3 | $72.9M | Buy |
|
|||||
|
2021
Q2 | $64.3M | Sell |
|
|||||
|
2021
Q1 | $80M | Hold |
|
|||||
|
2020
Q4 | $78.6M | Hold |
|
|||||
|
2020
Q3 | $76.4M | Buy |
|
|||||
|
2020
Q2 | $61.7M | Buy |
|
|||||
|
2020
Q1 | $49.8M | Hold |
|
|||||
|
2019
Q4 | $57.3M | Buy |
|
|||||
|
2019
Q3 | $37M | Sell |
|
|||||
|
2019
Q2 | $33.4M | Sell |
|
|||||
|
2019
Q1 | $35.2M | Sell |
|
|||||
|
2018
Q4 | $40.9M | Sell |
|
|||||
|
2018
Q3 | $54.3M | Sell |
|
|||||
|
2018
Q2 | $49.5M | Sell |
|
|||||
|
2018
Q1 | $66.7M | Hold |
|
|||||
|
2017
Q4 | $64.6M | Hold |
|
|||||
|
2017
Q3 | $67.2M | Sell |
|
|||||
|
2017
Q2 | $83.2M | Hold |
|
|||||
|
2017
Q1 | $81.2M | Hold |
|
|||||
|
2016
Q4 | $87.3M | Hold |
|
|||||
|
2016
Q3 | $80.6M | Buy |
|
|||||
|
2016
Q2 | $66.5M | Sell |
|
|||||
|
2016
Q1 | $80.2M | Buy |
|
|||||
|
2015
Q4 | $79.5M | Buy |
|
|||||
|
2015
Q3 | $37M | Sell |
|
|||||
|
2015
Q2 | $44.4M | Buy |
|
|||||
|
2015
Q1 | $31.5M | Buy |
|
|||||
|
2014
Q4 | $19.2M | Sell |
|
|||||
|
2014
Q3 | $28.7M | Sell |
|
|||||
|
2014
Q2 | $35.7M | Sell |
|
|||||
|
2014
Q1 | $46.2M | Buy |
|
|||||
|
2013
Q4 | $46.7M | Buy |
|
|||||
|
2013
Q3 | $32.2M | Buy |
|
|||||
|
2013
Q2 | $25.2M | Buy |
|